ÂÜÀòÂÒÂ×

Ben Pope is the Founder, President, and Chief Scientific Officer of MelliCell, Inc., since 2020, where focus lies on pioneering therapeutics for diabetes and obesity through innovative technology that models weight gain in human fat cells. Prior to this, Ben Pope was a Postdoctoral Fellow at Harvard University from 2015 to 2020, contributing to human adipocyte and islet engineering technology for diabetes and systems biology research. Ben Pope also served as a Graduate Research Assistant and Graduate Teaching Assistant at Florida State University between 2008 and 2014, where research involved chromosome and stem cell biology, alongside teaching laboratory courses. Earlier experience includes an Undergraduate Research Assistant role at Brigham Young University in 2007, working on hybrid tomato plants for genetic markers of viral resistance. Ben Pope holds a PhD in Cell and Molecular Biology from Florida State University and a BS in Genetics and Biotechnology from Brigham Young University.